Prevalence of illicit drug use in pregnant women in a Wisconsin private practice setting

American Journal of Obstetrics and Gynecology

Volumn 211, Issue 3, 2014, Pages 255.e1-255.e4

  Schauberger, Charles W ^a   Newbury, Emily J ^a   Colburn, Jean M ^a   Al Hamadani, Mohammed ^a  

^a GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

Author keywords

drug screening; illicit drug use; pregnancy; prenatal care

Indexed keywords

ALCOHOL; AMPHETAMINE; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CANNABIS; COCAINE; CODEINE; DIAMORPHINE; HYDROCODONE; ILLICIT DRUG; METHADONE; METHAMPHETAMINE; OPIATE; OXYCODONE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; DRUG ABUSE; DRUG SCREENING; DRUG URINE LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM SCREENING TEST; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; PRIVATE PRACTICE; PROSPECTIVE STUDY; QUESTIONNAIRE; SCREENING TEST; SUBSTANCE ABUSE; UNITED STATES; URINALYSIS;

DRUG SCREENING; ILLICIT DRUG USE; PREGNANCY; PRENATAL CARE;

ADOLESCENT; ADULT; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; PROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS; WISCONSIN;

EID: 85058205846     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2014.03.023     Document Type: Article

References (13)

1. Substance Abuse and Mental Health Services Administration. Results from the 2010 national survey on drug use and health: summary of national findings. 2011; NSDUH Series H-41, HHS Publication no. (SMA) 11-4658.
2. National Institute on Drug Abuse. DrugFacts: nationwide trends. Washington, DC: National Institutes of Health; 2014. Available at: http://www.drugabuse.gov/publications/drugfacts/nationwide-trends. Accessed July 5, 2013.
3. Centers for Disease Control and Prevention (CDC) Vital signs: overdoses of prescription opioid pain relievers and other drugs among women-United States, 1999-2010 MMWR Morb Mortal Wkly Rep 62 2013 537 542
4. L.K. Matti, and V.M. Caspersen Prevalence of drug use among pregnant women in a rural area J Obstet Gynecol Neonatal Nurs 22 1993 510 514
5. L. Dold, and M. Quirke Substance abuse and treatment needs of pregnant women in Wisconsin: executive summary and implications 1998 Wisconsin Survey Research Laboratory, University of Wisconsin-Extension Madison, WI Available at: www.dhs.wisconsin.gov/substabuse/docs/reports/pregexc.pdf Accessed July 5, 2013
6. S.H. Ebrahim, and J. Gfroerer Pregnancy-related substance use in the United States during 1996-1998 Obstet Gynecol 101 2003 374 379
7. M.L. Stitely, B. Calhoun, S. Maxwell, R. Nerhood, and D. Chaffin Prevalence of drug use in pregnant West Virginia patients W V Med J 106 2010 48 52
8. K.F. Buchi, S. Zone, K. Langheinrich, and M.W. Varner Changing prevalence of prenatal substance abuse in Utah Obstet Gynecol 102 2003 27 30
9. I.J. Chasnoff, H.J. Landress, and M.E. Barrett The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida N Engl J Med 322 1990 1202 1206
10. A. Azadi, and G.A. Dildy III Universal screening for substance abuse at the time of parturition Am J Obstet Gynecol 198 2008 e30 e32
11. American College of Obstetricians and Gynecologists. Committee on Health Care for Underserved Women, American Society of Addiction Medicine ACOG committee opinion no. 524: opioid abuse, dependence, and addiction in pregnancy Obstet Gynecol 119 2012 1070 1076
12. I.J. Chasnoff, R.F. McGourty, and G.W. Bailey et al. The 4P's Plus screen for substance use in pregnancy: clinical application and outcomes J Perinatol 25 2005 368 374
13. I.J. Chasnoff, A.M. Wells, R.F. McGourty, and L.K. Bailey Validation of the 4P's Plus screen for substance use in pregnancy J Perinatol 27 2007 744 748